Related Experiment Videos
[Preparation and characterization of potential antineoplastic agents]
1Semmelweis Orvostudományi Egyetem, Gyógyszerészi Kémiai Intézet, Budapest.
Acta Pharmaceutica Hungarica
|July 13, 1999
Summary
Researchers developed novel peptidomimetic protein tyrosine kinase (PTK) inhibitors targeting the pp60c-src enzyme. Some compounds showed significant PTK inhibition and induced apoptosis in colon tumor cells.
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Molecular Biology
Context:
- Protein tyrosine kinases (PTKs) are crucial in cell signaling and implicated in various cancers.
- The pp60c-src enzyme is a key PTK involved in cellular proliferation and survival.
- Developing targeted PTK inhibitors is a significant area of cancer research.
Purpose:
- To design and synthesize a combinatorial library of novel peptidomimetic compounds.
- To identify potential inhibitors targeting the substrate binding site of the pp60c-src enzyme.
- To explore structure-activity relationships for PTK inhibition.
Summary:
- A library of over 1600 compounds was synthesized, based on known PTK inhibitors with bis-aryl structures.
- Eleven bis-aryl compounds exhibited inhibitory activity against PTK in the 18-100 micromolar range.
- Molecular modeling revealed a consistent spatial arrangement of aromatic rings in active compounds, matching substrate conformations.
Impact:
- Identified promising lead compounds for peptidomimetic PTK inhibitors.
- Demonstrated significant PTK inhibitory activity and apoptosis induction in HT-29 colon tumor cells.
- Provides a foundation for further optimization of PTK inhibitors for cancer therapy.